AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 173 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | +27.3% | 43,873 | +43.8% | 0.00% | – |
| Q2 2022 | $11,000 | -86.2% | 30,502 | +28.4% | 0.00% | – |
| Q1 2021 | $80,000 | -80.0% | 23,759 | -83.4% | 0.00% | -100.0% |
| Q4 2020 | $400,000 | +8.1% | 142,806 | -3.2% | 0.00% | +100.0% |
| Q3 2020 | $370,000 | -83.8% | 147,538 | -12.1% | 0.00% | -90.9% |
| Q2 2020 | $2,278,000 | +37.1% | 167,813 | -23.4% | 0.01% | 0.0% |
| Q1 2020 | $1,661,000 | -22.7% | 219,106 | -35.6% | 0.01% | +57.1% |
| Q4 2019 | $2,150,000 | +50.1% | 340,175 | -6.9% | 0.01% | +40.0% |
| Q3 2019 | $1,432,000 | -68.3% | 365,347 | -60.9% | 0.01% | -68.8% |
| Q2 2019 | $4,524,000 | -6.1% | 934,650 | +58.8% | 0.02% | -11.1% |
| Q1 2019 | $4,819,000 | +119.0% | 588,408 | +47.9% | 0.02% | +80.0% |
| Q4 2018 | $2,200,000 | -18.6% | 397,804 | +30.0% | 0.01% | 0.0% |
| Q3 2018 | $2,703,000 | +20.8% | 306,119 | +36.5% | 0.01% | +11.1% |
| Q2 2018 | $2,238,000 | +16.6% | 224,219 | +11.3% | 0.01% | 0.0% |
| Q1 2018 | $1,920,000 | – | 201,419 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |